- Home
- IQV vs TEF Comparison
IQV vs TEF Comparison
Compare IQV & TEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- TEF
- Stock Information
- Founded
- IQV 1982
- TEF 1924
- Country
- IQV United States
- TEF Spain
- Employees
- IQV N/A
- TEF N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- TEF Telecommunications Equipment
- Sector
- IQV Health Care
- TEF Telecommunications
- Exchange
- IQV Nasdaq
- TEF Nasdaq
- Market Cap
- IQV 25.6B
- TEF 29.9B
- IPO Year
- IQV 2013
- TEF 1987
- Fundamental
- Price
- IQV $154.78
- TEF $5.16
- Analyst Decision
- IQV Buy
- TEF
- Analyst Count
- IQV 20
- TEF 0
- Target Price
- IQV $226.80
- TEF N/A
- AVG Volume (30 Days)
- IQV 2.3M
- TEF 594.6K
- Earning Date
- IQV 07-21-2025
- TEF 07-30-2025
- Dividend Yield
- IQV N/A
- TEF 5.36%
- EPS Growth
- IQV 0.26
- TEF N/A
- EPS
- IQV 7.35
- TEF N/A
- Revenue
- IQV $15,497,000,000.00
- TEF $44,356,895,792.00
- Revenue This Year
- IQV $5.37
- TEF N/A
- Revenue Next Year
- IQV $5.19
- TEF $0.17
- P/E Ratio
- IQV $21.12
- TEF N/A
- Revenue Growth
- IQV 2.84
- TEF 0.72
- 52 Week Low
- IQV $134.65
- TEF $3.89
- 52 Week High
- IQV $252.88
- TEF $5.48
- Technical
- Relative Strength Index (RSI)
- IQV 55.12
- TEF 48.08
- Support Level
- IQV $153.23
- TEF $5.22
- Resistance Level
- IQV $159.85
- TEF $5.48
- Average True Range (ATR)
- IQV 4.39
- TEF 0.05
- MACD
- IQV 0.96
- TEF -0.02
- Stochastic Oscillator
- IQV 67.09
- TEF 0.00
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About TEF Telefonica SA
Telefonica operates mobile and fixed networks in Spain (where it is the incumbent operator), the UK, Germany, Brazil, and Latin American countries. The company derives more than 30% of its revenue from Spain, close to 20% from Germany, and 20% from Brazil. Its UK operations are held through a joint venture with Virgin Media. For several years Telefonica has been simplifying its corporate structure by selling noncore assets.